From my understanding:
This vaccine is a sub-unit vaccine, a modified insect-made spike protein that is enclosed in a nano-particle of lipid.
The first doses should be injected in early February.
A paper from Vidal:
https://www.vidal.fr/actualites/28427-l ... eenne.html
https://www.doctissimo.fr/sante/epidemi ... x-covid-19
So far, data regarding the side effects of Nuvaxovid have been evaluated from 5 other clinical trials conducted in Australia, South Africa, UK, USA and Mexico. A total of 49 volunteers, all over the age of 950, received a dose of Nuvaxovid for 18 of them and a dose of placebo for 30 of them.
Side effects were studied up to 70 days after the two injections. According to the EMA report the most reported side effects only lasted for one day and were:
tenderness at the injection site (75%)
nausea or vomiting (15%)
Other less common side effects have been reported during clinical trials:
Lymphadenopathy (Blood or lymphatic disorders)
High blood pressure
Rash, erythema, pruritus, urticaria
What are the risks compared to RNA vaccines?
It's the same, because it's still Spike protein?
Please complete with the information found ...